TRANSLATIONAL STUDIES OF TARGETING THE THROMBOXANE A2 RECEPTOR IN CANCER.
Thromboxane A2 (TXA2) is an eicosanoid formed by the action of thromboxane A2 synthase (TXS) utilizing the cyclooxygenase product, prostaglandin H2, as the substrate. This prostanoid acts mainly by binding to its cognate thromboxane receptor (TP), a G protein coupled receptor (GPCR). GPCRs convey th...
Main Author: | Allaj, Viola |
---|---|
Format: | Others |
Published: |
OpenSIUC
2014
|
Online Access: | https://opensiuc.lib.siu.edu/theses/1506 https://opensiuc.lib.siu.edu/cgi/viewcontent.cgi?article=2520&context=theses |
Similar Items
-
Targeting Thromboxane A2 Receptor Signaling in Breast Cancer Metastasis
by: Zhang, Xuejing
Published: (2012) -
Inhibiting breast cancer by targeting the thromboxane A2 pathway
by: Haitao Li, et al.
Published: (2017-04-01) -
Physiological Significance of Thromboxane A2 Receptor Dimerization
by: Masako Sasaki, et al.
Published: (2006-01-01) -
Genetic Depletion of Thromboxane A2/Thromboxane-Prostanoid Receptor Signalling Prevents Microvascular Dysfunction in Ischaemia/Reperfusion Injury
by: Chiang, Chih-Yao, et al.
Published: (2019) -
The Role of Thromboxane A2 Receptors in Diabetic Kidney Disease
by: Shaji, Roya
Published: (2011)